<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>UAlberta: Judging Session</title>
        <link>https://video.igem.org/videos/watch/623f57b9-6163-4570-b821-addd3b640e35</link>
        <description>Despite their critical role in regulating cellular interactions and disease pathology, glycans remain a largely untapped therapeutic target. Current treatments for inflammatory eye diseases are limited by toxic side effects and poor ocular retention, with nearly an entire dose washed away in the blink of an eye. Enter gleyeco, a glycan-targeted drug delivery platform that harnesses engineered lectins to selectively anchor therapeutics to inflamed ocular tissues. Candidate lectins were optimized through in silico mutagenesis and binding simulations to improve glycan recognition while minimizing off-target interactions. Our constructs were then validated experimentally for binding performance and functional activity. To enable sustained, localized treatment, therapeutics are incorporated into a hydrogel-based contact lens system. By enhancing drug retention at the ocular surface, gleyeco aims to improve inflammation control, reduce dosing frequency, and minimize systemic effects. This modular approach extends beyond ocular inflammation, opening the door to glycan-targeted therapies tailored to diverse disease contexts.</description>
        <lastBuildDate>Sat, 21 Nov 2026 11:35:04 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>UAlberta: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/623f57b9-6163-4570-b821-addd3b640e35</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=623f57b9-6163-4570-b821-addd3b640e35" rel="self" type="application/rss+xml"/>
    </channel>
</rss>